SpectrumDNA, Inc.
SPXA
$0.00
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 352.31% | 16.31% | -10.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 352.31% | 16.31% | -10.25% |
| Cost of Revenue | -- | -- | -71.43% | -77.78% | -- |
| Gross Profit | -- | -- | 376.42% | 22.73% | -- |
| SG&A Expenses | -96.47% | -60.81% | -41.78% | -38.33% | -70.95% |
| Depreciation & Amortization | -82.14% | -45.16% | -28.57% | 83.33% | 3.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -96.25% | -60.65% | -41.40% | -37.02% | -72.94% |
| Operating Income | 96.25% | 60.65% | 58.82% | 39.81% | 70.85% |
| Income Before Tax | 95.42% | 60.42% | 61.67% | 510.24% | 70.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 95.42% | 60.42% | 61.67% | 510.24% | 70.91% |
| Earnings from Discontinued Operations | 100.58% | -39.11% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.52% | 16.17% | 61.67% | 510.24% | 27.02% |
| EBIT | 96.25% | 60.65% | 58.82% | 39.81% | 70.85% |
| EBITDA | 96.47% | 60.72% | 58.89% | 40.22% | 71.19% |
| EPS Basic | 98.51% | 16.46% | 64.65% | 397.54% | 48.06% |
| Normalized Basic EPS | 94.12% | 59.26% | 64.52% | 409.46% | 79.01% |
| EPS Diluted | 98.51% | 16.46% | 64.65% | 397.54% | 48.06% |
| Normalized Diluted EPS | 94.12% | 59.26% | 64.52% | 409.46% | 79.01% |
| Average Basic Shares Outstanding | 1.21% | 0.79% | 7.96% | 37.61% | 41.67% |
| Average Diluted Shares Outstanding | 1.21% | 0.79% | 7.96% | 37.61% | 41.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |